Palliation by Intratumoral Infiltration with Natural Interferon-beta

Publisher： Karger

E-ISSN： 2296-5262|24|4|362-366

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.24, Iss.4, 2001-09, pp. : 362-366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibodies to Commercially Available Interferon–Beta Molecules in Multiple Sclerosis Patients Treated with Natural Interferon–Beta

By  

International Archives of Allergy and Immunology, Vol. 118, Iss. 2-4, 1999-04 ,pp. : 368-371

Karger

Access to resources Recommend Favorite

Synergistic effects of interferon‐beta and nivolumab in oral mucosal melanoma

By  

THE JOURNAL OF DERMATOLOGY, Vol. 45, Iss. 1, 2018-01 ,pp. : 87-90

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 2 Trial of Interferon-Beta as Second-Line Treatment of Ovarian Cancer, Fallopian Tube Cancer, or Primary Carcinoma of the Peritoneum

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 343-346

Karger

Access to resources Recommend Favorite

Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon‐beta 1a: Case Report

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 5, 2015-05 ,pp. : e140-e145

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sequential Local Injection of Low-Dose Interferon-Beta for Maintenance Therapy in Stage II and III Melanoma: A Single-Institution Matched Case-Control Study

By  

Oncology, Vol. 82, Iss. 3, 2012-03 ,pp. : 139-146

Karger

Access to resources Recommend Favorite